Internal Limiting Membrane Removal during Macular Hole Surgery. Results of a Multicenter Retrospective Study

Ophthalmology

Volumn 113, Issue 8, 2006, Pages 1401-1410

  Tognetto, Daniele ^a   Grandin, Rosita ^a   Sanguinetti, Giorgia ^a   Minutola, Daniela ^a   Di Nicola, Marta ^b   Di Mascio, Rocco ^b   Ravalico, Giuseppe ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CILIARY DISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MEDICAL RECORD; OBSERVATIONAL STUDY; PEROPERATIVE CARE; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROBABILITY; PSEUDOPHAKIA; RETINA MACULA HOLE; RETINA SURGERY; RETROSPECTIVE STUDY; RISK FACTOR; SURGEON; TREATMENT FAILURE; TREATMENT OUTCOME; VITRECTOMY;

AGED; EPIRETINAL MEMBRANE; HUMANS; LOGISTIC MODELS; MIDDLE AGED; OPHTHALMOLOGIC SURGICAL PROCEDURES; PROGNOSIS; RETINAL PERFORATIONS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VISUAL ACUITY; VITRECTOMY;

EID: 33746311238     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2006.02.061     Document Type: Article

References (87)

1. Kelly N.E., and Wendel R.T. Vitreous surgery for idiopathic macular holes. results of a pilot study. Arch Ophthalmol 109 (1991) 654-659
2. Kwok A.K., Lai T.Y., Man-Chan W., and Woo D.C. Indocyanine green assisted internal limiting membrane removal in stage 3 or 4 macular hole surgery. Br J Ophthalmol 87 (2003) 71-74
3. Wendel R.T., Patel A.C., Kelly N.E., et al. Vitreous surgery for macular holes. Ophthalmology 100 (1993) 1671-1676
4. Haritoglou C., Gass C.A., Schaumberger M., et al. Long-term follow-up after macular hole surgery with internal limiting membrane peeling. Am J Ophthalmol 134 (2002) 661-666
5. Smiddy W.E., Feuer W., and Cordahi G. Internal limiting membrane peeling in macular hole surgery. Ophthalmology 108 (2001) 1471-1476
6. Freeman W.R., Azen S.P., Kim J.W., et al. Vitrectomy for the treatment of full-thickness stage 3 or 4 macular holes. results of a multicentered randomized clinical trial. Arch Ophthalmol 115 (1997) 11-21
7. Ruby A.J., Williams D.F., Grand M.G., et al. Pars plana vitrectomy for treatment of stage 2 macular holes. Arch Ophthalmol 112 (1994) 359-364
8. Orellana J., and Lieberman R.M. Stage III macular hole surgery. Br J Ophthalmol 77 (1993) 555-558
9. Ryan Jr. E.H., and Gilbert H.D. Results of surgical treatment of recent-onset full-thickness idiopathic macular holes. Arch Ophthalmol 112 (1994) 1545-1553
10. Brooks Jr. H.L. Macular hole surgery with and without internal limiting membrane peeling. Ophthalmology 107 (2000) 1939-1948
11. Mester V., and Kuhn F. Internal limiting membrane removal in the management of full-thickness macular holes. Am J Ophthalmol 129 (2000) 769-777
12. Margherio R.R., Margherio A.R., Williams G.A., et al. Effect of perifoveal tissue dissection in the management of acute idiopathic full-thickness macular holes. Arch Ophthalmol 118 (2000) 495-498
13. Ando F., Sasano K., Ohba N., et al. Anatomic and visual outcome after indocyanine green-assisted peeling of the retinal internal limiting membrane in idiopathic macular hole surgery. Am J Ophthalmol 137 (2004) 609-614
14. Thompson J.T., Glaser B.M., Sjaarda R.N., et al. Effects of intraocular bubble duration in the treatment of macular holes by vitrectomy and transforming growth factor-beta 2. Ophthalmology 101 (1994) 1195-1200
15. Minihan M., Goggin M., and Cleary P.E. Surgical management of macular holes. results using gas tamponade alone, or in combination with autologous platelet concentrate, or transforming growth factor beta 2. Br J Ophthalmol 81 (1997) 1073-1079
16. Glaser B.M., Michels R.G., Kuppermann B.D., et al. Transforming growth factor-beta 2 for the treatment of full-thickness macular holes. a prospective randomized study. Ophthalmology 99 (1992) 1162-1172
17. Banker A.S., Freeman W.R., Azen S.P., et al. A multicentered clinical study of serum as adjuvant therapy for surgical treatment of macular holes. Arch Ophthalmol 117 (1999) 1499-1502
18. Morris R., Kuhn F., and Witherspoon C.D. Retinal folds and hemorrhagic macular cysts in Terson's syndrome. Ophthalmology 101 (1994) 1
19. Liesenhoff O., Messmer E.M., Pulur A., and Kampik A. Surgical management of complete macular foramina. [in German]. Ophthalmloge 93 (1996) 655-659
20. Uemoto R., Yamamoto S., Aoki T., et al. Macular configuration determined by optical coherence tomography after idiopathic macular hole surgery with or without internal limiting membrane peeling. Br J Ophthalmol 86 (2002) 1240-1242
21. Kuhn F. Point. to peel or not to peel, that is the question. Ophthalmology 109 (2002) 9-11
22. Hassan T.S., and Williams G.A. Counterpoint: to peel or not to peel: is that the question?. Ophthalmology 109 (2002) 11-12
23. Byhr E., and Lindblom B. Macular hole surgery without routine membrane excision or use of adjuvants. Acta Ophthalmol Scand 78 (2000) 451-455
24. Park D.W., Sipperley J.O., Sneed S.R., et al. Macular hole surgery with internal-limiting membrane peeling and intravitreous air. Ophthalmology 106 (1999) 1392-1397
25. Scott I.U., Moraczewski A.L., Smiddy W.E., et al. Long-term anatomic and visual acuity outcomes after initial anatomic success with macular hole surgery. Am J Ophthalmol 135 (2003) 633-640
26. Benson W.E., Cruickshanks K.C., Fong D.S., et al. Surgical management of macular holes. a report by the American Academy of Ophthalmology. Ophthalmology 108 (2001) 1328-1335
27. Sheidow T.G., Blinder K.J., Holekamp N., et al. Outcome results in macular hole surgery. An evaluation of internal limiting membrane peeling with and without indocyanine green. Ophthalmology 110 (2003) 1697-1701
28. Da Mata A.P., Burk S.E., Riemann C.D., et al. Indocyanine green-assisted peeling of the retinal internal limiting membrane during vitrectomy surgery for macular hole repair. Ophthalmology 108 (2001) 1187-1192
29. Gandorfer A., Messmer E.M., Ulbig M.W., and Kampik A. Indocyanine green selectively stains the internal limiting membrane. Am J Ophthalmol 131 (2001) 387-388
30. Kadonosono K., Itoh N., Uchio E., et al. Staining of internal limiting membrane in macular hole surgery. Arch Ophthalmol 118; (2000) 1116-1118
31. Burk S.E., Da Mata A.P., Snyder M.E., et al. Indocyanine green-assisted peeling of the retinal internal limiting membrane. Ophthalmology 107 (2000) 2010-2014
32. Kwok A.K., Li W.W., Pang C.P., et al. Indocyanine green staining and removal of internal limiting membrane in macular hole surgery. histology and outcome. Am J Ophthalmol 132 (2001) 178-183
33. Haritoglou C., Ehrt O., Gass C.A., et al. Paracentral scotomata. a new finding after vitrectomy for idiopathic macular hole. Br J Ophthalmol 85 (2001) 231-233
34. Gass C.A., Haritoglou C., Messmer E.M., et al. Peripheral visual field defects after macular hole surgery. a complication with decreasing incidence. Br J Ophthalmol 85 (2001) 549-551
35. Welch J.C. Dehydration injury as a possible cause of visual field defect after pars plana vitrectomy for macular hole. Am J Ophthalmol 124 (1997) 698-699
36. Haritoglou C., Gass C.A., Gandorfer A., and Kampik A. ICG-assisted peeling of the retinal ILM. Ophthalmology 109 (2002) 1039 author reply 1040-1
37. Haritoglou C., Gandorfer A., Gass C.A., et al. Indocyanine green-assisted peeling of the internal limiting membrane in macular hole surgery affects visual outcome. a clinicopathologic correlation. Am J Ophthalmol 134 (2002) 836-841
38. Haritoglou C., Gass C.A., Schaumberger M., et al. Macular changes after peeling of the internal limiting membrane in macular hole surgery. Am J Ophthalmol 132 (2001) 363-368
39. Engelbrecht N.E., Freeman J., Sternberg Jr. P., et al. Retinal pigment epithelial changes after macular hole surgery with indocyanine green-assisted internal limiting membrane peeling. Am J Ophthalmol 133 (2002) 89-94
40. Tadayoni R., Paques M., Girmens J.F., et al. Persistence of fundus fluorescence after use of indocyanine green for macular surgery. Ophthalmology 110 (2003) 604-608
41. Ho J.D., Tsai R.J., Chen S.N., and Chen H.C. Cytotoxicity of indocyanine green on retinal pigment epithelium. implications for macular hole surgery. Arch Ophthalmol 121 (2003) 1423-1429
42. Terasaki H., Miyake Y., Nomura R., et al. Focal macular ERGs in eyes after removal of macular ILM during macular hole surgery. Invest Ophthalmol Vis Sci 42 (2001) 229-234
43. Gass C.A., Haritoglou C., Schaumberger M., and Kampik A. Functional outcome of macular hole surgery with and without indocyanine green-assisted peeling of the internal limiting membrane. Graefes Arch Clin Exp Ophthalmol 241 (2003) 716-720
44. Tornambe P.E., Poliner L.S., and Coehn R.G. Definition of macular hole surgery end points. elevated/open, flat/open, flat/closed. [letter]. Retina 18 (1998) 286-287
45. Aaberg T.M., Blair C.J., and Gass J.D. Macular holes. Am J Ophthalmol 69 (1970) 555-562
46. Patel A.C., and Wendel R.T. Vitrectomy for macular hole. Semin Ophthalmol 9 (1994) 47-55
47. Willis A.W., and Garcia-Cosio J.F. Macular hole surgery. comparison of longstanding versus recent macular holes. Ophthalmology 103 (1996) 1811-1814
48. Ullrich S., Haritoglu C., Gass C., et al. Macular hole size as a prognostic factor in macular hole surgery. Br J Ophthalmol 86 (2002) 390-393
49. Scott R.A., Ezra E., West J.F., and Gregor Z.J. Visual and anatomical results of surgery for long standing macular holes. Br J Ophthalmol 84 (2000) 150-153
50. Kobayashi H., and Kobayashi K. Correlation of quantitative three-dimensional measurements of macular hole size with visual acuity after vitrectomy. Graefes Arch Clin Exp Ophthalmol 237 (1999) 283-288
51. Ip M.S., Baker B.J., Duker J.S., et al. Anatomical outcomes of surgery for idiopathic macular hole as determined by optical coherence tomography. Arch Ophthalmol 120 (2002) 29-35
52. Tornambe P.E., Poliner L.S., and Grote K. Macular hole surgery without face-down positioning. a pilot study. Retina 17 (1997) 179-185
53. Goldbaum M.H., McCuen B.W., Hanneken A.M., et al. Silicone oil tamponade to seal macular holes without position restrictions. Ophthalmology 105 (1998) 2140-2147
54. Liggett P.E., Skolik D.S., Horio B., et al. Human autologous serum for the treatment of full-thickness macular holes. a preliminary study. Ophthalmology 102 (1995) 1071-1076
55. Paques M., Chastang C., Mathis A., et al. Effect of autologous platelet concentrate in surgery for idiopathic macular hole. results of a multicenter, double-masked, randomized trial. Ophthalmology 106 (1999) 932-938
56. Olsen T.W., Sternberg Jr. P., Capone Jr. A., et al. Macular hole surgery using thrombin-activated fibrinogen and selective removal of the internal limiting membrane. Retina 18 (1998) 322-329
57. Smiddy W.E., Pimentel S., and Williams G.A. Macular hole surgery without using adjunctive additives. Ophthalmic Surg Lasers 28 (1997) 713-717
58. Thompson J.T., Smiddy W.E., Williams G.A., et al. Comparison of recombinant transforming growth factor-beta-2 and placebo as an adjunctive agent for macular hole surgery. Ophthalmology 105 (1998) 700-706
59. Gaudric A., Massin P., Paques M., et al. Autologous platelet concentrate for the treatment of full-thickness macular holes. Graefes Arch Clin Exp Ophthalmol 233 (1995) 549-554
60. Lai J.C., Stinnett S.S., and McCuen B.W. Comparison of silicone oil versus gas tamponade in the treatment of idiopathic full-thickness macular hole. Ophthalmology 110 (2003) 1170-1174
61. Karia N., Laidlaw A., West J., et al. Macular hole surgery using silicone oil tamponade. Br J Ophthalmol 85 (2001) 1320-1323
62. Pertile G., and Claes C. Silicone oil vs. gas for the treatment of full-thickness macular hole. Bull Soc Belge Ophtalmol 274 (1999) 31-36
63. Gass J.D. Idiopathic senile macular hole. its early stages and pathogenesis. Arch Ophthalmol 106 (1988) 629-639
64. Schultz P.N., Sobol W.M., and Weingeist T.A. Long-term visual outcome in Terson syndrome. Ophthalmology 98 (1991) 1814-1819
65. Gass J.M. Muller cell cone, an overlooked part of the anatomy of the fovea centralis. hypotheses concerning its role in the pathogenesis of macular hole and foveomacular retinoschisis. Arch Ophthalmol 117 (1999) 821-823
66. Yooh H.S., Brooks Jr. H.L., Capone Jr. A., et al. Ultrastructural features of tissue removed during idiopathic macular hole surgery. Am J Ophthalmol 122 (1996) 67-75
67. Cheng L., Azen S.P., El-Bradey M.H., et al. Effects of preoperative and postoperative epiretinal membranes on macular hole closure and visual restoration. Ophthalmology 109 (2002) 1514-1520
68. Yamanishi S., Oshima Y., Emi K., and Motokura M. Optical cross-sectional evaluation of successfully repaired idiopathic macular holes by retinal thickness analyzer. Retina 20 (2000) 450-458
69. Paques M., Massin P., Santiago P.Y., et al. Late reopening of successfully treated macular holes. Br J Ophthalmol 81 (1997) 658-662
70. Paques M., Massin P., Blain P., et al. Long-term incidence of reopening of macular holes. Ophthalmology 107 (2000) 760-765
71. Christmas N.J., Smiddy W.E., and Flynn Jr. H.W. Reopening of macular holes after initially success repair. Ophthalmology 105 (1998) 1835-1838
72. Messmer E., Heidenkummer H., and Kampik A. Ultrastructure of epiretinal membranes associated with macular holes. Graefes Arch Clin Exp Ophthalmol 236 (1998) 248-254
73. Blain P., Paques M., Massin P., et al. Epiretinal membranes surrounding idiopathic macular holes. Retina 18 (1998) 316-321
74. Kurihara K., Ishibashi T., and Oshima K. The residual epiretinal membrane after vitrectomy for macular hole. Graefes Arch Clin Exp Ophthalmol 237 (1999) 648-653
75. Funata M., Wendel R.T., de la Cruz Z., and Green W.R. Clinicopathologic study of bilateral macular holes treated with pars plana vitrectomy and gas tamponade. Retina 12 (1992) 289-298
76. Gass J.D. Reappraisal of biomicroscopic classification of stages of development of a macular hole. Am J Ophthalmol 119 (1995) 752-759
77. Rosa Jr. R.H., Glaser B.M., de la Cruz Z., and Green W.R. Clinicopathologic correlation of an untreated macular hole and a macular hole treated by vitrectomy, transforming growth factor-beta 2, and gas tamponade. Am J Ophthalmol 122 (1996) 853-863
78. Takahashi I., and Kishi S. Tomographic features of early macular hole closure after vitreous surgery. Am J Ophthalmol 130 (2000) 192-196
79. Thompson J.T., Sjaarda R.N., and Lansing M.B. The results of vitreous surgery for chronic macular holes. Retina 17 (1997) 493-501
80. Thompson J.T., Smiddy W.E., Glaser B.M., et al. Intraocular tamponade duration and success of macular hole surgery. Retina 16 (1996) 373-382
81. Gandorfer A., Haritoglou C., Gass C.A., et al. Indocyanine green-assisted peeling of the internal limiting membrane may cause retinal damage. Am J Ophthalmol 132 (2001) 431-433
82. Miura M., Elsner A.E., Osako M., et al. Dissociated optic nerve fiber layer appearance after internal limiting membrane peeling for idiopathic macular hole. Retina 23 (2003) 561-563
83. Sippy B.D., Engelbrecht N.E., Hubbard G.B., et al. Indocyanine green effect on cultured human pigment epithelial cells. implication for macular hole surgery. Am J Ophthalmol 132 (2001) 433-435
84. Sakamoto T., Itaya K., Noda Y., and Ishibashi T. Retinal pigment epithelial changes after indocyanine green-assisted vitrectomy. Retina 22 (2002) 794-796
85. Haritoglou C., Gandorfer A., Schaumberger M., et al. Light-adsorbing properties and osmolarity of indocyanine-green depending on concentration and solvent medium. Invest Ophthalmol Vis Sci 44 (2003) 2722-2729
86. Gandorfer A., Haritoglou C., Gandorfer A., and Kampik A. Retinal damage from indocyanine green in experimental macular surgery. Invest Ophthalmol Vis Sci 44 (2003) 316-323
87. Sebag J. Indocyanine green-assisted macular hole surgery. too pioneering?. Am J Ophthalmol 137 (2003) 744-746